Evidence map›Paper›PMID 34022383›Full record

ArticleNeuroImage2021

Integrating large-scale neuroimaging research datasets: Harmonisation of white matter hyperintensity measurements across Whitehall and UK Biobank datasets.

Valentina Bordin, Ilaria Bertani, Irene Mattioli, Vaanathi Sundaresan, Paul McCarthy, Sana Suri, Enikő Zsoldos, Nicola Filippini, Abda Mahmood, Luca Melazzini and 10 more

Abstract read
In one paragraph

Article in NeuroImage, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Association of cerebral small vessel disease burden with brain structure and cognitive and vascular risk trajectories in mid-to-late life.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Study Protocol: The Heart and Brain Study.Frontiers in physiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Valentina BordinWellcome Centre for Integrative Neuroimaging, Oxford Centre for Functional MRI of the Brain, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK; Department of Electronics, Information and Bioengineering, Politecnico di Milano, Milan, Italy.
Ilaria BertaniWellcome Centre for Integrative Neuroimaging, Oxford Centre for Functional MRI of the Brain, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK; Department of Electronics, Information and Bioengineering, Politecnico di Milano, Milan, Italy.
Irene MattioliWellcome Centre for Integrative Neuroimaging, Oxford Centre for Functional MRI of the Brain, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK; Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Italy.
Vaanathi SundaresanWellcome Centre for Integrative Neuroimaging, Oxford Centre for Functional MRI of the Brain, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Paul McCarthyWellcome Centre for Integrative Neuroimaging, Oxford Centre for Functional MRI of the Brain, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Sana SuriWellcome Centre for Integrative Neuroimaging, Oxford Centre for Human Brain Activity, Department of Psychiatry, University of Oxford, Oxford, UK; Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, UK.
Enikő ZsoldosWellcome Centre for Integrative Neuroimaging, Oxford Centre for Functional MRI of the Brain, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK; Wellcome Centre for Integrative Neuroimaging, Oxford Centre for Human Brain Activity, Department of Psychiatry, University of Oxford, Oxford, UK; Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, UK.
Nicola FilippiniWellcome Centre for Integrative Neuroimaging, Oxford Centre for Human Brain Activity, Department of Psychiatry, University of Oxford, Oxford, UK.
Abda MahmoodDepartment of Psychiatry, Warneford Hospital, University of Oxford, Oxford, UK.
Luca MelazziniWellcome Centre for Integrative Neuroimaging, Oxford Centre for Functional MRI of the Brain, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK; Department of Biomedical Sciences for Health, Università degli Studi di Milano, Milan, Italy.
Maria Marcella LaganàIRCCS Fondazione Don Carlo Gnocchi ONLUS, Milan, Italy.
Giovanna ZamboniWellcome Centre for Integrative Neuroimaging, Oxford Centre for Functional MRI of the Brain, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK; Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Italy.
Archana Singh-ManouxINSERM U1153, Epidemiology of Ageing and Neurodegenerative diseases, Université de Paris, Paris, France; Department of Epidemiology and Public Health, University College London, London, UK.
Mika KivimäkiDepartment of Epidemiology and Public Health, University College London, London, UK.
Klaus P EbmeierDepartment of Psychiatry, Warneford Hospital, University of Oxford, Oxford, UK.
Giuseppe BaselliDepartment of Electronics, Information and Bioengineering, Politecnico di Milano, Milan, Italy.
Mark JenkinsonWellcome Centre for Integrative Neuroimaging, Oxford Centre for Functional MRI of the Brain, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Clare E MackayWellcome Centre for Integrative Neuroimaging, Oxford Centre for Functional MRI of the Brain, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK; Wellcome Centre for Integrative Neuroimaging, Oxford Centre for Human Brain Activity, Department of Psychiatry, University of Oxford, Oxford, UK; Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, UK; Oxford Health NHS Foundation Trust, Oxford, UK.
Eugene P DuffWellcome Centre for Integrative Neuroimaging, Oxford Centre for Functional MRI of the Brain, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK; Department of Paediatrics, University of Oxford, Oxford, UK.
Ludovica GriffantiWellcome Centre for Integrative Neuroimaging, Oxford Centre for Functional MRI of the Brain, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK; Wellcome Centre for Integrative Neuroimaging, Oxford Centre for Human Brain Activity, Department of Psychiatry, University of Oxford, Oxford, UK. Electronic address: ludovica.griffanti@psych.ox.ac.uk.

Funding

Education, socioeconomic status and Aging: transitions from multimorbidity to functional limitations and mortalityR01AG056477 · NIA · UNIVERSITY COLLEGE LONDON · PI KIVIMAKI, MIKA J, SINGH-MANOUX, ARCHANA · 2018 to 2022
$2.8M
Role of mid- and late-life risk factors in social inequalities in Alzheimer's Disease and Related DementiasRF1AG062553 · NIA · INSERM PARIS 5 · PI KIVIMAKI, MIKA J, SINGH-MANOUX, ARCHANA · 2019 to 2019
$1.5M
Department of HealthMedical Research Council G1001354Medical Research Council MC_EX_MR/N50192X/1Medical Research Council MC_PC_17228Medical Research Council MC_QA137853Medical Research Council MR/K013351/1Medical Research Council MR/L023784/2Medical Research Council MR/M024962/1Medical Research Council MR/R024227/1Medical Research Council MR/S011676/1Medical Research Council S011676NIA NIH HHS R01 AG056477NIA NIH HHS RF1 AG062553Wellcome TrustWellcome Trust 203139/Z/16/ZWellcome Trust 215573/Z/19/Z
6 · The paper itself

Abstract

Large scale neuroimaging datasets present the possibility of providing normative distributions for a wide variety of neuroimaging markers, which would vastly improve the clinical utility of these measures. However, a major challenge is our current poor ability to integrate measures across different large-scale datasets, due to inconsistencies in imaging and non-imaging measures across the different protocols and populations. Here we explore the harmonisation of white matter hyperintensity (WMH) measures across two major studies of healthy elderly populations, the Whitehall II imaging sub-study and the UK Biobank. We identify pre-processing strategies that maximise the consistency across datasets and utilise multivariate regression to characterise study sample differences contributing to differences in WMH variations across studies. We also present a parser to harmonise WMH-relevant non-imaging variables across the two datasets. We show that we can provide highly calibrated WMH measures from these datasets with: (1) the inclusion of a number of specific standardised processing steps; and (2) appropriate modelling of sample differences through the alignment of demographic, cognitive and physiological variables. These results open up a wide range of applications for the study of WMHs and other neuroimaging markers across extensive databases of clinical data.

Indexed as

AgingBiomedical ResearchDatasets as TopicLeukoaraiosisMulticenter Studies as TopicNeuroimagingAdultAgedAged, 80 and overBiological Specimen BanksFemaleHumansLongitudinal StudiesMaleMiddle AgedUnited KingdomHarmonisationMRIUK BiobankWhite matter hyperintensities

Identifiers

PMID34022383
PMCPMC8285593

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.